Integrated Investment Consultants’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $359K | Sell |
684
-210
| -23% | -$110K | 0.07% | 196 |
|
2025
Q1 | $567K | Buy |
894
+285
| +47% | +$181K | 0.11% | 136 |
|
2024
Q4 | $434K | Buy |
609
+39
| +7% | +$27.8K | 0.09% | 177 |
|
2024
Q3 | $599K | Buy |
570
+262
| +85% | +$275K | 0.13% | 122 |
|
2024
Q2 | $296K | Hold |
308
| – | – | 0.08% | 201 |
|
2024
Q1 | $296K | Buy |
+308
| New | +$296K | 0.08% | 201 |
|
2018
Q2 | – | Sell |
-22
| Closed | -$8K | – | 575 |
|
2018
Q1 | $8K | Buy |
+22
| New | +$8K | ﹤0.01% | 670 |
|
2017
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 631 |
|